Impact of Genomics and Personalised Medicine on Current Practice of Clinical Cardiology
نویسنده
چکیده
Genomic and systems biology advances are predicated to change the way medicine is practiced in the future. The focus will be for patient or participant driven effort to maintain wellness and to identify disease onset at very early genetic and epigenetic levels. There is potential for re-alignment of the abnormal biology towards normal with medicine and therapy individualised for that particular participant. This is the basis for so-called personalised medicine and P4 medicine [1-3].
منابع مشابه
Current Genomics in Cardiovascular Medicine
Cardiovascular disease (CVD) is a heterogeneous, complex trait that has a major impact on human morbidity and mortality. Common genetic variation may predispose to common forms of CVD in the community, and rare genetic conditions provide unique pathogenetic insights into these diseases. With the advent of the Human Genome Project and the genomic era, new tools and methodologies have revolutioni...
متن کاملThe personalised medicine. A paradigm of evidence-based medicine.
The practice of "evidence-based medicine" aims at the conscientious, explicit and judicious use of the current best evidence in making decisions about the individualised patient care. The clinical genetics evolved from translational genetics research and contributes to the clinical care of patients and families through evidence-based health care in managing inherited disorders through accurate ...
متن کاملHighlights from the 2013 WIN Symposium: personalised cancer therapy from innovation to implementation
The Worldwide Innovative Networking (WIN) consortium is a global alliance of academic and industrial cancer researchers, clinicians, and cancer advocacy groups set up to promote innovations in personalised cancer therapy and to accelerate the translation of research in this discipline into the oncology clinic. One of its most important initiatives is the WIN symposia, which have been held in Pa...
متن کاملPersonalised Medicine Possible With Real-Time Integration of Genomic and Clinical Data To Inform Clinical Decision-Making
Despite widespread use of genomic sequencing in research, there are gaps in our understanding of the performance and provision of genomic sequencing in clinical practice. The Melbourne Genomics Health Alliance (the Alliance), has been established to determine the feasibility, performance and impact of using genomic sequencing as a diagnostic tool. The Alliance has partnered with BioGrid Austral...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014